Participant Baseline for pubmed_id 24243014 in PSD
| PID_in_paper | age(yr) | gender | race/ethnicity | infection_duration | pre_ART_duration | ART | ART_duration | pre_suppression_duration | suppression_duration | proviral_DNA_copies_at_sampling | viral_RNA_copies_at_sampling | suppression_status | CD4_at_sampling | sample_comment |
|---|
| 10 | 47 (year) | M | white | | | TDF/FTC, ATZ/r | | 66 (month) | 60 (month) | | <50 (copies/mL) | suppressed | | |
| 17 | 49 (year) | M | Africa American | | | ZDV/3TC, EFV, ATZ/r | | 141 (month) | 57 (month) | | <50 (copies/mL) | suppressed | | |
| 19 | 46 (year) | F | Africa American | | | ABC/3TC, NVP | | 45 (month) | 105 (month) | | <50 (copies/mL) | suppressed | | |
| 9 | 57 (year) | M | Africa American | | | TDF/FTC, FPV/r | | 19 (month) | 28 (month) | | <50 (copies/mL) | suppressed | | |
| 20 | 75 (year) | F | Africa American | | | ABC/3TC/ZDV, TDF, LPV/r | | 81 (month) | 88 (month) | | <50 (copies/mL) | suppressed | | |
| 16 | 59 (year) | M | Africa American | | | FTC, EFV, ATZ/r | | 51 (month) | 33 (month) | | <50 (copies/mL) | suppressed | | |
| 23 | 38 (year) | M | Africa American | | | ABC/3TC/EFV | | 118 (month) | 108 (month) | | <50 (copies/mL) | suppressed | | |
